News | April 25, 2023
Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr
The business and product range of Ipca and that of Unichem complements each others business and product range
The business and product range of Ipca and that of Unichem complements each others business and product range
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Essex enriches and complements Emmes’ services
Proposed combination enhances Pfizer’s position as a leading company in oncology
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Natural Capsules Limited's shareholding will be reduced to 89.99%
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Subscribe To Our Newsletter & Stay Updated
